Category: Pharma Industry

Massachusetts Senate Passes 340B Contract Pharmacy Protections for Certain 340B Grantees, Hospitals

November 28, 2023 William Newton, Associate Editor/Senior Writer Views

Massachusetts lawmakers are expected to vote on Sen. Pavel Payano's (D) 340B PBM nondiscrimination bill Thursday.

Massachusetts state senators this month unanimously passed a healthcare bill that would protect 340B grantees and certain safety net hospitals [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Provides Benefits, Needs Reform, Says Literature Review

November 28, 2023 Tom Mirga, Editor at Large Views

A JAMA Health Network literature review found that the 340B program provides a range of benefits but needs reforms.

The 340B program has provided a range of benefits but also needs reforms, according to a recent review of published [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B’s Footprint in Medicare Part D Is Growing, Study Says

November 28, 2023 Tom Mirga, Editor at Large Views

A JAMA Health Forum study co- authored by Sean Dickson found the 340B program's footprint in Medicare Part D is increasing.

340B covered entities captured nearly half (49.9%) of their 340B-eligible prescriptions billed to Medicare Part D in 2020, up from [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Senate Democrats Seek Drug Pricing Testimony from Three Pharma CEOs

November 28, 2023 William Newton, Associate Editor/Senior Writer Views

Sen. Bernie Sanders (I-Vt.) and 10 Democrats on an influential committee invited the CEOs of three pharma companies to testify at a January hearing.

Senate Democrats on an influential committee invited the CEOs of three major pharmaceutical companies to testify at a January hearing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Two Drugmakers Offer Refunds for 340B Overcharges

November 28, 2023 Tom Mirga, Editor at Large Views

Two drugmakers, Mallinckrodt's subsidiary SpecGx and Novo Nordisk, owe refunds to 340B providers for certain overcharges.

Two drugmakers will offer refunds to 340B providers for overcharges in recent years. Drug manufacturer Mallinckrodt’s SpecGx generic pharmaceutical subsidiary [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Michigan Bill Introduced to Protect 340B Contract Pharmacy Arrangements

November 17, 2023 William Newton, Associate Editor/Senior Writer Views

Michigan state Rep. Alabas Farhat (D) introduced a bipartisan bill designed to protect 340B contract pharmacy arrangements in the state.

Michigan state lawmakers this week introduced a bill designed to protect 340B contract pharmacy arrangements from drug manufacturer restrictions. On [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Reforms Urged by Centrist Democrat Group with Drugmaker Ties

November 17, 2023 Rich Daly, Editor in Chief Views

Darbin Wofford, a health policy advisor at Third Way, said his organization is urging Congressional Democrats to adopt 340B program reforms.

A center-left group that has received pharmaceutical industry funding is urging a series of 340B reforms that it hopes to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Jazz Pharmaceuticals Posts Refund Notice on HRSA Website

November 17, 2023 Rich Daly, Editor in Chief Views

Jazz Pharmaceuticals owes refunds to 340B providers, according to a notice posted on HRSA's website.

Jazz Pharmaceuticals owes refunds to 340B providers, according to a notice posted on the Health Resources and Services Administration’s Office [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Lilly to Exempt Arkansas Providers from New Tighter 340B Contract Pharmacy Restrictions

November 15, 2023 William Newton, Associate Editor/Senior Writer Views

Eli Lilly is conducting government approved 340B provider audits that for the first time look for certain Medicaid health plan duplicate discounts.

Pharmaceutical giant Eli Lilly will exempt Arkansas covered entities from its latest 340B contract pharmacy restrictions in response to an [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Court Sets November 2024 Trial for Novo Nordisk’s Arkansas 340B Lawsuit

November 15, 2023 William Newton, Associate Editor/Senior Writer Views

Novo Nordisk and the Arkansas Insurance Department are at odds over whether a federal district court should intervene in the enforcement of Arkansas' 340B contract pharmacy law.

The trial for drugmaker Novo Nordisk’s legal challenge to Arkansas’ 340B contract pharmacy law will wait a year to commence. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live